CASE DISCUSSION
Molecular and Genetic studies in Gynaecological Malignancies
Presented from India by Dr. Rajiv Dhall0
Likes
1990
Views
80
Shares
100
Bookmarks
0
Credit Points
0
Learning Hours
0
CPD/CME Points
0
Courses Completed
Case Description
Molecular and genetic studies in gynecological malignancies have revolutionized diagnostics, prognostics, and targeted therapies. Advances in genomic sequencing have identified key mutations in ovarian (BRCA1/2, TP53), endometrial (PTEN, MSI), and cervical cancers (HPV integration, PIK3CA). These...
Case Summary
- Gynecological cancer management has shifted from surgery, chemotherapy, and radiotherapy to a molecular and genetic approach due to advances in molecular biology and genetics, leading to better treatment guidelines and vaccine development. The rising incidence of gynecological cancers parallels overall cancer increases, attributed to unhealthy lifestyles, obesity, smoking, environmental pollution, radiation exposure, and infections like HPV, which is communicable and linked to cervical and vaginal cancers.
Speaker Profile
Dr. Rajiv Dhall
Alumni- PGIMERConsultant Obstetrics & Gynaecologist, Peerless Hospitex Hospital & Research Center Ltd, Kolkata
Disclosures
Assimilate requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. All relevant financial relationships for anyone with the ability to control the content of this educational activity have been reviewed and mitigated. Others involved in the planning of this activity have no relevant financial relationships.